Literature DB >> 9869659

Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism.

H Cao1, A Girard-Globa, F Berthezene, P Moulin.   

Abstract

High density lipoprotein (HDL)-associated paraoxonase (PON) seems to play a major role in the protection of low density lipoprotein (LDL) against peroxidation by HDL, and the partly purified enzyme exerts a dose-dependent protective effect. A common polymorphism of the human gene (192 Q-->R) modulates paraoxonase activity but purified enzyme from either genotype is equally effective against LDL peroxidation. The inhibition of Cu2+-induced LDL peroxidation by HDL was monitored by lipid peroxide assay and change in LDL electrophoretic mobility. We show that HDL from type 2 diabetic patients with the QQ or RR genotype (n = 12 for each) reduce, to the same extent, both peroxide production (by 60.6 +/- 20.0 and 63.9 +/- 23.5%) and relative change in mobility (61.3 +/- 21.8 and 61.4 +/- 26.5%) despite a 6-fold difference in paraoxonase activity (47.4 +/- 4.4 vs. 299.7 +/- 23.7 U/l, P < 0.0001). Protection was, however, related to paraoxonase activity, but with a different efficiency in each group corresponding to a better protection per unit of enzyme in the QQ genotype group. Inactivation of PON activity by heating (56 degreesC, 10 min) or by EDTA was totally without effect on protection, which remained correlated with the paraoxonase activity measured prior to inactivation. In summary, these results suggest that the protein bearing both paraoxonase and arylesterase activities also possesses a third thermostable property, closely associated with paraoxon hydrolysis activity and unaffected by PON genetic variability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9869659

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.

Authors:  Luis M Moura; Susana Faria; Miguel Brito; Fausto J Pinto; Steen D Kristensen; Isabel M Barros; Nalini Rajamannan; Francisco Rocha-Gonçalves
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

2.  Paraoxonase 1 gene polymorphisms influence clinical features of open-angle glaucoma.

Authors:  Yoko Inagaki; Yukihiko Mashima; Tomoyo Funayama; Yuichiro Ohtake; Nobuo Fuse; Noriko Yasuda; Takeo Fukuchi; Akira Murakami; Yoshihiro Hotta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

3.  Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk.

Authors:  Mahmoud Merhi; Sally Demirdjian; Essa Hariri; Nada Sabbah; Sonia Youhanna; Michella Ghassibe-Sabbagh; Joseph Naoum; Marc Haber; Raed Othman; Samer Kibbani; Elie Chammas; Roy Kanbar; Hamid El Bayeh; Youssef Chami; Antoine Abchee; Daniel E Platt; Pierre Zalloua; Georges Khazen
Journal:  Inflamm Res       Date:  2015-04-24       Impact factor: 4.575

4.  Effect of single bout of maximal exercise on plasma antioxidant status and paraoxonase activity in young sportsmen.

Authors:  A Otocka-Kmiecik; M Lewandowski; R Stolarek; U Szkudlarek; D Nowak; M Orlowska-Majdak
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

5.  Paraoxonase 1 status in the Thai population.

Authors:  Wimon Phuntuwate; Chuthamanee Suthisisang; Banhan Koanantakul; Michael I Mackness; Bharti Mackness
Journal:  J Hum Genet       Date:  2005-05-28       Impact factor: 3.172

6.  Dietary cholesterol increases paraoxonase 1 enzyme activity.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Rebecca J Richter; Julieann K Marshall; Karen S Nakayama; Ella R Jarvik; Jason F Eintracht; Elisabeth A Rosenthal; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2012-08-15       Impact factor: 5.922

7.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Authors:  V H Brophy; R L Jampsa; J B Clendenning; L A McKinstry; G P Jarvik; C E Furlong
Journal:  Am J Hum Genet       Date:  2001-05-02       Impact factor: 11.025

8.  Hydrolysis of platelet-activating factor by human serum paraoxonase.

Authors:  L Rodrigo; B Mackness; P N Durrington; A Hernandez; M I Mackness
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

9.  Serum paraoxonase activity and protein thiols in chronic renal failure patients.

Authors:  M Prakash; J K Shetty; L Rao; S Sharma; A Rodrigues; R Prabhu
Journal:  Indian J Nephrol       Date:  2008-01

10.  Serum Paraoxonase (PON1) Activity in North-West Indian Punjabi's with Acute Myocardial Infarction.

Authors:  V Nagarjuna Maturu; Nidhi Gupta; Gagandip Singh; Kirandip Gill; Yash Paul Sharma; Surjit Singh
Journal:  Indian J Clin Biochem       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.